Schroder Investment Management Group Embecta Corp. Transaction History

Schroder Investment Management Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $1.05 Million - $1.55 Million	-69,819 Reduced 60.39%	45,801 $689,000
Q2 2023 Aug 11, 2023	SELL	$21.6 - $30.69 $91,735 - $130,340	-4,247 Reduced 3.54%	115,620 $2.5 Million
Q1 2023 May 11, 2023	BUY	$23.07 - $32.77 $2.77 Million - $3.93 Million	119,867 New	119,867 $3.37 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.12B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.